Medicenna Synthetic Control Arm Success Story

Key takeaways: In Phase 2, the SCA enabled Medicenna to better understand the expected survival benefit for their treatment. This knowledge supported their proposed hybrid Phase 3 design. In a precedent-setting regulatory decision, the FDA agre…

Medidata Acorn AI Intelligent Trials

The answer…stronger data. Data made meaningful through proven analytics and expertise. Medidata Acorn AI Intelligent Trials analytics are built on the largest and only cross-industry real-time site level data to make the right tri…